ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Windtree Therapeutics Com

Windtree Therapeutics Com (DSCO)

3,50
0,00
(0,00%)
À la fermeture: 28 Novembre 10:00PM
3,50
0,00
( 0,00% )
Après les heures de négociation: -

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
3,50
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
3,50
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

DSCO Dernières nouvelles

Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT)

Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT) Corporate Rebranding Initiative Reflects New Direction for Company PR Newswire WARRINGTON, Pa., April 18, 2016...

Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business Updates

Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business Updates Company Remains on Track to Deliver Key AEROSURF® Phase 2 Program Milestones PR Newswire WARRINGTON...

Discovery Labs to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Thursday, March 24, 2016

Discovery Labs to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Thursday, March 24, 2016 PR Newswire WARRINGTON, Pa., March 16, 2016 WARRINGTON, Pa., March 16, 2016...

Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire WARRINGTON, Pa., Feb. 3, 2016 WARRINGTON, Pa., Feb. 3, 2016 /PRNewswire/ -- Discovery Laboratories, Inc...

Discovery Labs Announces Appointment of New Chief Executive Officer and Provides an Update on AEROSURF® Phase 2 Program

Discovery Labs Announces Appointment of New Chief Executive Officer and Provides an Update on AEROSURF® Phase 2 Program PR Newswire WARRINGTON, Pa., Feb. 1, 2016 WARRINGTON, Pa., Feb. 1, 2016...

Discovery Labs Announces Reverse Stock Split

Discovery Labs Announces Reverse Stock Split PR Newswire WARRINGTON, Pa., Jan. 21, 2016 WARRINGTON, Pa., Jan. 21, 2016 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) today...

Discovery Labs Announces Initiation of AEROSURF® Phase 2b Clinical Trial

Discovery Labs Announces Initiation of AEROSURF® Phase 2b Clinical Trial PR Newswire WARRINGTON, Pa., Dec. 29, 2015 WARRINGTON, Pa., Dec. 29, 2015 /PRNewswire/ -- Discovery Laboratories, Inc...

Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot...

Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot Topics in Neonatology Annual Meeting PR Newswire WARRINGTON, Pa., Dec...

Discovery Labs Announces Top Line Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestati...

Discovery Labs Announces Top Line Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Encouraging phase 2a data suggest that aerosolized KL4...

Discovery Labs to Announce Results from AEROSURF® Phase 2a Expansion Clinical Trial

Discovery Labs to Announce Results from AEROSURF® Phase 2a Expansion Clinical Trial Conference Call Scheduled for Thursday, November 12, 2015 at 8:00 a.m. Eastern Time PR Newswire WARRINGTON...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ONCOOnconetix Inc
US$ 0,923
(39,43%)
371,21k
BMRABiomerica Inc
US$ 0,4297
(33,41%)
10,01M
BSLKBolt Projects Holdings Inc
US$ 0,35
(18,24%)
75,79k
MDAISpectral AI Inc
US$ 1,72
(17,81%)
397,03k
BOCNBlue Ocean Acquisition Corporation
US$ 15,51
(12,80%)
10,42k
APLTApplied Therapeutics Inc
US$ 1,8799
(-78,06%)
8,95M
TOIIWOncology Institute Inc
US$ 0,0135
(-28,57%)
5,82k
CMAXCareMax Inc
US$ 0,3046
(-27,73%)
469,89k
IDAIT Stamp Inc
US$ 0,7141
(-14,99%)
9,48M
TCBPTC BioPharm Holdings PLC
US$ 0,5146
(-14,23%)
168,65k
CRKNCrown Electrokinetics Corporation
US$ 0,308
(10,35%)
12,07M
BMRABiomerica Inc
US$ 0,437
(35,67%)
10,01M
PGHLPrimega Group Holdings Ltd
US$ 1,82
(10,30%)
9,7M
IDAIT Stamp Inc
US$ 0,7141
(-14,99%)
9,48M
APLTApplied Therapeutics Inc
US$ 1,88
(-78,06%)
8,95M
Aucune Discussion Trouvée
Ajouter une Discussion